Modification of the human allergic immune response by allergen- DNA-transfected dendritic cells in vitro

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 2, 2004, Pages 327-333

  Klostermann, Bettina ^a,c   Bellinghausen, Iris ^a   Böttcher, Ingo ^a   Petersen, Arnd ^b   Becker, Wolf Meinhard ^b   Knop, Jürgen ^a   Saloga, Joachim ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Adenoviral transfection; Allergy; Dendritic cells; TH1 T H2

Indexed keywords

ADENOVIRUS VECTOR; ALLERGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; IODINE 123; PHLPI PROTEIN, PHLEUM PRATENSE; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

ARTICLE; ATOPY; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA TRANSFECTION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 1142285209     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.10.067     Document Type: Article

References (21)

1. Lambrecht BN. The dendritic cell in allergic airway diseases: a new player to the game. Clin Exp Allergy 2001;31:206-18.
2. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-72.
3. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
4. Spiegelberg HL, Raz E. DNA-based approaches to the treatment of allergies. Curr Opin Mol Ther 2002;4:64-71.
5. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
6. Steitz J, Bruck J, Knop J, Tuting T. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Ther 2001;8:1255-63.
7. Zhong L, Granelli Piperno A, Choi Y, Steinman RM. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 1999;29:964-72.
8. Suck R, Hagen S, Cromwell O, Fiebig H. Rapid and efficient purification of Phleum pratense major allergens Phl p 1 and group Phl p 2/3 using a two-step procedure. J Immunol Methods 1999;229:73-80.
9. Petersen A, Schramm G, Bufe A, Schlaak M, Becker WM. Structural investigations of the major allergen Phl p I on the complementary DNA and protein level. J Allergy Clin Immunol 1995;95:987-94.
10. Bellinghausen I, Brand U, Knop J, Saloga J. Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol 2000;105:988-96.
11. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 1992;20:363-90.
12. Horner AA, Nguyen MD, Ronaghy A, Cinman N, Verbeek S, Raz E. DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice. J Allergy Clin Immunol 2000;106:349-56.
13. Horner AA, Van Uden JH, Zubeldia JM, Broide D, Raz E. DNA-based immunotherapeutics for the treatment of allergic disease. Immunol Rev 2001;179:102-18.
14. Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 1996;93:5141-5.
15. H2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase. Int Arch Allergy Immunol 2001;124: 406-10.
16. Sudowe S, Montermann E, Steitz J, Tuting T, Knop J, Reske-Kunz AB. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther 2002;9:147-56.
17. Song W, Kong HL, Carpenter H, Torii H, Granstein R, Rafii S, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 1997;186:1247-56.
18. Juillard V, Villefroy P, Godfrin D, Pavirani A, Venet A, Guillet JG. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol 1995;25:3467-73.
19. Mincheff M, Altankova I, Zoubak S, Tchakarov S, Botev C, Petrov S, et al. In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer - changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile. Crit Rev Oncol Hematol 2001;39:125-32.
20. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, et al. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 1997;4:17-25.
21. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.